Literature DB >> 7082553

Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.

T Philip, G M Lenoir, P A Bryon, R Gerard-Marchant, G Souillet, N Philippe, F Freycon, M Brunat-Mentigny.   

Abstract

In a retrospective analysis of 87 cases of Caucasian childhood non-Hodgkin malignant lymphoma (NHML) from Lyon, France, all the case were diffuse lymphomas, but 47 were diagnosed as monomorphic small non-cleaved NHML, pathologically indistinguishable from Burkitt's lymphoma (BL). BL could then be the most frequent childhood lymphoma in France. This homogeneous series allows better definition of the characteristics of BL within NHML. Age distribution is similar to that of endemic BL, with a sex ratio of 3.7/1. Abdominal masses are initially present in 68% of the cases, whereas jaw is involved in only 4%. The disease is characterized by its overwhelming evolution in the absence of therapy. However, complete remission (CR) is usually obtained after the first chemtherapy regimen. Most relapses occur at 3-8 months. Death could be related to cerebrospinal fluid (CSF) involvement, local recurrence or secondary marrow involvement. Ninety per cent of the patients alive with no evidence of disease (NED) 8 months after CR can be considered as definitely cured. Our study on Caucasian children with NHML indicates that, from histological and clinical criteria, nearly half the cases are very similar to African BL. Even though EBV rarely associated with our cases, BL could be a worldwide lymphoma.

Entities:  

Mesh:

Year:  1982        PMID: 7082553      PMCID: PMC2011007          DOI: 10.1038/bjc.1982.107

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival.

Authors:  J C Arseneau; G P Canellos; P M Banks; C W Berard; H R Gralnick; V T DeVita
Journal:  Am J Med       Date:  1975-03       Impact factor: 4.965

2.  American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations.

Authors:  P M Banks; J C Arseneau; H R Gralnick; G P Canellos; V T DeVita; C W Berard
Journal:  Am J Med       Date:  1975-03       Impact factor: 4.965

3.  Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.

Authors:  S Garwicz; T Landberg; M Akerman
Journal:  Acta Paediatr Scand       Date:  1974-09

4.  Antibodies to Epstein-Barr virus (EBV) antigens in sera of American Burkitt lymphoma patients.

Authors:  D V Ablashi; G B De-Thé; J M Easton; A Liabeuf; P H Levine; G R Armstrong
Journal:  Biomedicine       Date:  1974-07

5.  Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma.

Authors:  Y Hirshaut; M H Cohen; D A Stevens
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

6.  Burkitt's lymphoma: clinical features of North American cases.

Authors:  P H Levine; B R Cho
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

7.  Histopathological definition of Burkitt's tumour.

Authors: 
Journal:  Bull World Health Organ       Date:  1969-04       Impact factor: 9.408

8.  Burkitt's tumor in the United States.

Authors:  M H Cohen; J M Bennett; C W Berard; J L Ziegler; C L Vogel; J N Sheagren; P P Carbone
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

9.  Observations on Burkitt's tumour in central and northern Canada.

Authors:  J Hoogstraten
Journal:  Int J Cancer       Date:  1967-11-15       Impact factor: 7.396

10.  Burkitt's tumour in England. A comparison with childhood lymphosarcoma.

Authors:  D H Wright
Journal:  Int J Cancer       Date:  1966-09-15       Impact factor: 7.396

View more
  8 in total

1.  Characteristics of Burkitt's lymphoma in India.

Authors:  V P Choudhry; R K Agarwal; R K Marwah
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

2.  Autoantibodies in three populations of Burkitt's lymphoma patients.

Authors:  E Vainio; G M Lenoir; R M Franklin
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

Review 3.  Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.

Authors:  M A Epstein; A J Morgan
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

4.  Immunophenotypic analysis of childhood Burkitt's lymphoma in the West Midlands 1957-1986.

Authors:  T J Jones; N A Coad; K R Muir; S E Parkes; C D Evans; J R Mann
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

5.  Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.

Authors:  S Finerty; M Rowe; P J Berry; D L Ranson; M G Mott; C D Gregory; A B Rickinson
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

6.  Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol.

Authors:  A Atra; J D Imeson; R Hobson; M Gerrard; I M Hann; O B Eden; R L Carter; C R Pinkerton
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

7.  Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.

Authors:  A Atra; M Gerrard; R Hobson; J D Imeson; S Ashley; C R Pinkerton
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

8.  Abdominal Burkitt-type lymphomas in Algeria.

Authors:  Y Ladjadj; T Philip; G M Lenoir; F Z Tazerout; K Bendisari; R Boukheloua; P Biron; M Brunat-Mentigny; M Aboulola
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.